Agenus Inc. , a leader in immuno-oncology, today shared new data on botensilimab (BOT) and balstilimab (BAL) at the American Society of Clinical Oncology Gastrointestinal Cancers Symposium (ASCO GI) ...
Tyra Biosciences, Inc. , a clinical-stage biotechnology company focused on developing next-generation precision medicines that target large opportunities in Fibroblast Growth Factor Receptor (FGFR) ...
Casdozokitug, in combination with atezolizumab/bevacizumab, final data demonstrate durability of response and improvement in depth of response including a 17.2% complete response rate – – Antitumor ...
Barchart on MSN3d
Masco's Q4 2024 Earnings: What to ExpectMasco Corporation (MAS), headquartered in Livonia, Michigan, is a global leader in designing, manufacturing, and distributing ...
First-ever corporation to top Corporate Knights Global 100 twice14th consecutive year in Global 100 index, 7th top 10 ranking Follows strong 2024 performance in other key ESG ratings ...
The leading and longest established online Process Engineering publication serving the Process Manufacturing Industries ...
3d
Laramie Energy deployed ASCO zero-emissions electric dump valves to comply with state regulations, reduce maintenance and ...
This Phase 1b/2, open-label, multicenter dose escalation and expansion combination study of ADG126 in combination with Merck’s (known as MSD outside of the US and Canada) anti-PD-1 therapy, KEYTRUDA ® ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback